CUE HEALTH INC (HLTH) Forecast, Price Target & Analyst Ratings
NASDAQ:HLTH • US2297901009
0.0434 USD
-0.02 (-29.77%)
At close: Jun 5, 2024
0.0489 USD
+0.01 (+12.67%)
After Hours: 6/5/2024, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CUE HEALTH INC (HLTH).
Forecast Snapshot
Consensus Price Target
$0.51
+ 1,075.12% Upside
Next Earnings Forecast
Release DateAug 7, 2024
PeriodQ1 / 2024
EPS Estimate-$0.38
Revenue Estimate10.305M
ChartMill Buy Consensus
43.33%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.51
Upside
+ 1,075.12%
From current price of $0.04 to mean target of $0.51, Based on 6 analyst forecasts
Low
$0.51
Median
$0.51
High
$0.53
Price Target Revisions
1 Month
-33.33%
3 Months
-52.94%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for HLTH. The average price target is 0.51 USD. This implies a price increase of 1075.12% is expected in the next year compared to the current price of 0.0434.
The average price target has been revised downward by 52.94% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
HLTH was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HLTH.
In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
HLTH was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-03-14 | BTIG | Downgrade | Buy -> Neutral |
| 2023-11-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-06-05 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-06-02 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-05-15 | BTIG | Maintains | Buy |
| 2023-05-01 | Goldman Sachs | Maintains | Buy |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-10-21 | Goldman Sachs | Maintains | Buy |
| 2022-08-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-19 | Cowen & Co. | Initiate | Outperform |
| 2021-10-19 | Goldman Sachs | Initiate | Buy |
| 2021-10-19 | Morgan Stanley | Initiate | Equal-Weight |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 7, 2024
PeriodQ1 / 2024
EPS Estimate-$0.38
Revenue Estimate10.305M
Revenue Q2Q-58.39%
EPS Q2Q38.03%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-65.07%
EPS (1 Month)
0.00%
EPS (3 Months)
-46.75%
Next Earnings Summary
HLTH is expected to report earnings on 8/7/2024. The consensus EPS estimate for the next earnings is -0.38 USD and the consensus revenue estimate is 10.30M USD.
The next earnings revenue estimate has been revised downward by 65.07% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 618.1M 2,587.39% | 483.5M -21.78% | 70.936M -85.33% | 58.123M -18.06% | 111.99M 92.68% | 211.49M 88.85% | 387.03M 83.00% | |
| EBITDA YoY % growth | 222.71M 673.70% | -158.76M -171.29% | -240.436M -51.45% | -150.685M 37.33% | -119.842M 20.47% | -172.937M -44.30% | 36.674M 121.21% | |
| EBIT YoY % growth | 190.2M 521.73% | -203.7M -207.10% | -296.714M -45.66% | -229.875M 22.53% | -183.098M 20.35% | -112.06M 38.80% | -38.2M 65.91% | |
| Operating Margin | 30.77% | -42.13% | -418.28% | -395.50% | -163.50% | -52.99% | -9.87% | |
| EPS YoY % growth | N/A | -1.01 -202.61% | -2.56 -153.47% | -1.12 56.30% | -0.66 40.73% | -0.21 68.46% | -0.28 -31.71% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 38.03% | -0.30 45.60% | -0.26 39.91% | -0.24 75.21% | -0.22 41.59% | -0.19 35.23% | -0.18 30.92% | -0.16 33.57% |
| Revenue Q2Q % growth | 10.305M -58.39% | 9.742M -1.56% | 13.683M -21.71% | 25.662M 36.51% | 26.316M 155.37% | 19.38M 98.93% | 23.868M 74.44% | 32.436M 26.40% |
| EBITDA Q2Q % growth | -27.132M 64.27% | -25.704M 52.73% | -25.5M 4.54% | -26.52M -194.47% | -20.298M 25.19% | -18.36M 28.57% | -15.708M 38.40% | -14.892M 43.85% |
| EBIT Q2Q % growth | -58.615M 33.39% | -55.833M 29.15% | -53.89M 16.71% | -52.846M 19.05% | -48.552M 17.17% | -45.492M 18.52% | -41.82M 22.40% | -40.902M 22.60% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
24.25%
EPS Next 5 Year
17.29%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
43.74%
Revenue Next 5 Year
52.69%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
13.08%
EBIT Next 5 Year
20.63%
CUE HEALTH INC / HLTH Forecast FAQ
What is the average price target for CUE HEALTH INC (HLTH) stock?
6 analysts have analysed HLTH and the average price target is 0.51 USD. This implies a price increase of 1075.12% is expected in the next year compared to the current price of 0.0434.
Can you provide the upcoming earnings date for CUE HEALTH INC?
CUE HEALTH INC (HLTH) will report earnings on 2024-08-07, after the market close.
What are the consensus estimates for CUE HEALTH INC (HLTH) next earnings?
The consensus EPS estimate for the next earnings of CUE HEALTH INC (HLTH) is -0.38 USD and the consensus revenue estimate is 10.30M USD.
Can you provide the analyst count for CUE HEALTH INC stock?
The number of analysts covering CUE HEALTH INC (HLTH) is 6.